Cell death releases a fat-regulating protein into blood in mice
In mouse experiments, triggering three forms of liver cell death raised blood levels of the protein; drugs targeting each process reduced the increases.
Our read
Mechanisms- Studied:
- Experiments in mice with induced liver cell death, against mice receiving cell-death inhibitors
- What changed:
- Blood ACBP/DBI was higher after induced liver cell death in mice without cell-death inhibitors than in inhibitor-treated mice
- The catch:
- Cell-death inhibitors could alter ACBP/DBI release through off-target effects
- Stake:
- An author founded Osasuna Therapeutics. An author founded Samsara Therapeutics.
- In the record:
- One of 4 papers on ACBP on record: 3 with results in people.
Editor of record: Boris Djordjevic · AgingResearch.News
The 1,198 hospitalized adults in a human cohort analysis included 903 with COVID-19 and 295 uninfected controls. Their blood levels of acyl-CoA-binding protein, which regulates fat metabolism inside cells, were associated with inflammation and signs of organ dysfunction.
Mouse experiments showed that organ injury raised blood levels of the protein. Inducing three forms of liver cell death also raised levels; inhibitors targeting each process reduced the increases. In human liver cancer and leukemia cells grown in the lab, the protein escaped as dying cells’ outer membranes became leaky. A meta-analysis of more than 100,000 people linked higher blood levels to disease and future illness. Together, the authors concluded, the findings identify cell death as a mechanism linking organ injury to increased circulating protein.
Why it matters
Blood levels of this protein rose with age in human cohorts. Understanding its release bears on whether those levels could help track tissue damage across organs.
Caveats
The authors note that they inferred which organs supplied the protein in humans from correlations between blood proteins, rather than direct tissue measurements.
From the paper
- Participants
… following PCR testing for SARS-CoV-2 and included 903 COVID-19-positive adults and 295 hospitalized SARS-CoV-2-negative controls.
Methods, SomaScan-based correlation analyses and tissue enrichment of ACBP/DBI-associated proteins
- Limitation
First, organ-specific contributions in humans are inferred from proteomic correlations and therefore require direct tissue-level validation.
Quoted word for word from the full text on nature.com.
The paper
Inserm; Centre National de la Recherche Scientifique
Cell Death and Differentiation, Jun 3, 2026, Open access


Comments
Be the first to comment.